PH26372A - Novel medicinal use of 5-(2-chloroethyl)-4-methylthiazole or a salt or solvate thereof - Google Patents

Novel medicinal use of 5-(2-chloroethyl)-4-methylthiazole or a salt or solvate thereof Download PDF

Info

Publication number
PH26372A
PH26372A PH40041A PH40041A PH26372A PH 26372 A PH26372 A PH 26372A PH 40041 A PH40041 A PH 40041A PH 40041 A PH40041 A PH 40041A PH 26372 A PH26372 A PH 26372A
Authority
PH
Philippines
Prior art keywords
prevention
treatment
methylthiazole
chloroethyl
solvate
Prior art date
Application number
PH40041A
Other languages
English (en)
Inventor
Bernard Robin Boar
Alan John Cross
Alfred Richard Green
Original Assignee
Astra Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astra Ab filed Critical Astra Ab
Publication of PH26372A publication Critical patent/PH26372A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Biomedical Technology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Epidemiology (AREA)
  • Hospice & Palliative Care (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Vascular Medicine (AREA)
  • Psychiatry (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Polymerization Catalysts (AREA)
  • Addition Polymer Or Copolymer, Post-Treatments, Or Chemical Modifications (AREA)
PH40041A 1989-02-17 1990-02-12 Novel medicinal use of 5-(2-chloroethyl)-4-methylthiazole or a salt or solvate thereof PH26372A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE8900564A SE8900564D0 (sv) 1989-02-17 1989-02-17 Novel medicinal use

Publications (1)

Publication Number Publication Date
PH26372A true PH26372A (en) 1992-06-01

Family

ID=20375091

Family Applications (1)

Application Number Title Priority Date Filing Date
PH40041A PH26372A (en) 1989-02-17 1990-02-12 Novel medicinal use of 5-(2-chloroethyl)-4-methylthiazole or a salt or solvate thereof

Country Status (16)

Country Link
EP (1) EP0458892B1 (de)
JP (1) JP3007683B2 (de)
KR (1) KR0139221B1 (de)
AT (1) ATE107166T1 (de)
AU (1) AU643431B2 (de)
CA (1) CA2045618A1 (de)
DE (1) DE69009989T2 (de)
DK (1) DK0458892T3 (de)
ES (1) ES2055421T3 (de)
HK (1) HK44597A (de)
IE (1) IE64622B1 (de)
IL (1) IL93243A (de)
NZ (1) NZ232499A (de)
PH (1) PH26372A (de)
SE (1) SE8900564D0 (de)
WO (1) WO1990009174A1 (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HRP921128B1 (en) * 1991-10-30 1998-10-31 Sandor Garaczy Novel process for the preparation of 4-methyl-5(2-chloroethyl)-thiazole and analogues thereof
SE9802119D0 (sv) 1998-06-15 1998-06-15 Astra Ab New use
SE9901658D0 (sv) * 1999-05-06 1999-05-06 Astra Ab New formulation
SE9904177D0 (sv) * 1999-11-18 1999-11-18 Astra Ab Novel compounds

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE196140C1 (de) * 1964-01-01

Also Published As

Publication number Publication date
AU5167990A (en) 1990-09-05
SE8900564D0 (sv) 1989-02-17
EP0458892A1 (de) 1991-12-04
ES2055421T3 (es) 1994-08-16
CA2045618A1 (en) 1990-08-18
IL93243A0 (en) 1990-11-29
DE69009989T2 (de) 1994-10-13
EP0458892B1 (de) 1994-06-15
IE900460L (en) 1990-08-17
IL93243A (en) 1994-08-26
NZ232499A (en) 1992-12-23
HK44597A (en) 1997-04-18
WO1990009174A1 (en) 1990-08-23
ATE107166T1 (de) 1994-07-15
AU643431B2 (en) 1993-11-18
IE64622B1 (en) 1995-08-23
JP3007683B2 (ja) 2000-02-07
KR0139221B1 (en) 1998-05-15
KR920700641A (ko) 1992-08-10
DE69009989D1 (de) 1994-07-21
DK0458892T3 (da) 1994-08-15

Similar Documents

Publication Publication Date Title
DE69100282T3 (de) Verwendung insulin-sensiblisierender wirkstoffe zur behandlung von hypertonie.
US20210069159A1 (en) Bach1 Inhibitors in Combination with Nrf2 Activators and Pharmaceutical Compositions Thereof
WO2021218638A1 (zh) 用于糖尿病及其并发症治疗的联合用药及其药物组合物
EP2114398B1 (de) Isosorbid-mononitrat-derivate zur behandlung von okularer hypertonie
JPS6154006B2 (de)
WO2001082919B1 (en) Methods of and compounds for inhibiting calpains
CN105963244A (zh) 注射用青蒿琥酯制剂及其应用
PH26372A (en) Novel medicinal use of 5-(2-chloroethyl)-4-methylthiazole or a salt or solvate thereof
IE64936B1 (en) Heteroaryl-3-oxo-propanenitrile derivatives useful in stimulating myelopoiesis
WO1998016224A1 (de) Pyrazolinone zur behandlung von potenzstörungen
DE60017733T2 (de) Verwendung von riluzol zur behandlung multipler sklerose
KR100342367B1 (ko) 녹내장치료제및안압강하제
CA2454544A1 (en) Optic nerve protecting agents containing .alpha.1 receptor blocker as active ingredient
US5399572A (en) Chlormethiazole in the treatment of neurodegeneration
AU2020337177B2 (en) Therapeutic methods and uses thereof
CA2554082C (en) Use of epothilones in the treatment of neuronal connectivity defects such as schizophrenia and autism
CN114025767A (zh) 一种含有头孢哌酮钠和他唑巴坦钠的药物组合物及其应用
JPH04503512A (ja) 新規な医薬用途
Chen Aliphatic versus aromatic amines as vasoconstrictors
US6291493B1 (en) Treatment of spinal cord injuries
Midtvedt Penicillins, cephalosporins and tetracyclines
US20080194466A1 (en) (5Z)-5-(6-Quinoxalinylmethylidene)-2-[(2,4,6-Trichlorophenyl)Amino]-1,3-Thiazol-4(5H)-One
EP0874840A1 (de) Dibenzothiepin derivate und pharmazeutische zusammenstellungen
CN1156408A (zh) (S)-腺苷基-L-甲硫氨酸(SAMe)及其生理上耐受的盐治疗暂时局部缺血病灶引起的再灌注损伤的用途